November 2017

HepatoSure® - 100 donor pooled Human Hepatocytes

HepatoSure is a mixed gender pool of human hepatocytes, which has been designed to facilitate DMPK applications with a more consistent hepatocyte product year after year - little variation from lot-to-lot and large lot sizes.

Get 20% discount off two selected lots of HepatoSure

Liver fractions with High Aldehyde Oxidase and Xanthine Oxidase activity

New test systems ( Pooled Human Liver S9 and cytosol) by Sekisui Xenotech are prepared from tissue treated to preserve high Aldehyde Oxidase (AO) and Xanthine Oxidase (XO) activity, yet without significantly impacting major cytochrome P450 (CYP) activity.

Read more and download the poster presented at the ISSX Meeting

Single-donor Human hepatocytes for Suspension

These hepatocytes are a preferred test system for phase I and II in vitro drug metabolism studies. Sekisui XenoTech’s human hepatocytes for suspension come in three different assured minimum yield (AMY) categories, and for a short time at a very attractive price.

60% discount end-of-year clearance sale

TransiPort Cells: Ready-To-Use Transporter Studies in vitro System
Webinar - November 9th, 2017 - 11am

Genomembrane and tebu-bio look forward to you joining them for this webinar during which we invite you to discover TransiPort cells, robust tools for drug-drug interaction studies.

Sign-up for this free webinar here

Recent publications - Sekisui Xenotech 

In this e-newsletter, you've been able to discover some of Sekisui Xenotech's products. The two recent publications below incorporate contributions by their scientists.

In vitro studies with two Human organic anion transporters: OAT2 & OAT7

DDI Guidance Recommendations on Down-regulation, CYP2C Induction and CYP2B6 control

Choose your topics! Subscribe to tebu-bio's newsletters on your favourite research themes